Ethical Considerations for Automobile Emissions Management Background, Detriment, and Litigation (Published)
Volkswagen’s diesel emissions have triggered different litigations from the EPA and other agencies. This research will analyze potential justification to the upper management and the engineers of Volkswagen. Maintaining trust between society, customers, and car manufacturers is essential. This research will provide strategies for automobile manufacturers to mitigate the potential recurrence of litigation risks. Manufacturers and engineers should ensure that the cars can successfully maintain consumers’ trust. The author recommends that automobile manufacturers should focus on global markets and improve its ethical and regulatory standards. Additionally, this research emphasizes that a company has ethical obligations to disclose facts and mitigate future risks for improving reputation and devices. Moreover, this research encourages upper management and engineers to solve the emission problem by improving technological innovation to decrease emissions. The author believes that car manufacturers have social and ethical responsibilities when designing devices. They should lower emissions for climate change and public health reasons. Furthermore, this research provides insights on what manufacturers could learn from the Volkswagen scandal, which highlights that cooperation among the company, experts, and government agencies is essential. It encourages manufacturers’ teams to consider different ethical approaches when designing devices to protect individuals’ health and the environment.
Keywords: Automobile emissions, common good approach, ethical considerations, technological innovation, utilitarianism approach
The Influence of M&A on Technological Innovation and Performance Results—Based On the Empirical Study of Gem Listed Companies (Published)
In the recent wave of M&A, listed companies on the GEM have paid great attention to acquiring relevant technology and knowledge assets. In order to enhance their technological innovation capabilities, they also concern about the technology which can improve their defects when choosing the M&A targets. Correspondingly, the acquisition of new technologies and new products through M&A has become one of the typical motivations among the listed companies on the GEM in China in recent years. This phenomenon has gradually attracted the attention of domestic scholars. In China, the research on M&A behavior of GEM listed companies, especially the study on technology innovation and performance results of M&A behavior, still lags behind the development of practice. This paper takes China’s GEM listed companies as the specific research object, selects its relevant data in 2011-2016, and objectively discusses the impact of M&A on the technological innovation and performance results, and has carried out the empirical analysis based on the related data, which shows that the R&D investment will decrease and the technological innovation performance will increase after M&A. Finally, based on the empirical results and the actual situation of the current market, this paper puts forward two practical suggestions for the M&A and technological innovation and performance results of China’s GEM listed companies.
Keywords: Innovation Performance, M & A, technological innovation
Decision Support Systems: Creating Value For Marketing Decisions In The Pharmaceutical Industry (Published)
Purpose: The purpose of this study is to analyze the impact of decision support systems to creating value for marketing decisions in the pharmaceutical industry. Methodology: This paper was completed with the help of an extensive literature study on decision support/business intelligence and pharmaceutical industry marketing available on the databases and websites. Primary data has been used in this paper to check the impact of information technology market performance. The SPSS software package is used to analyze the employee responses and statistical technique. Regression analysis is used to check the impact of information technology on market performance. Findings: 150 questionnaires were being given to stakeholders in different pharmaceutical companies located in Pakistan. 104 were collected back and 96 questionnaires are considered valid and used are for analysis. After analyzing the data, we find that information technology has significant impact on market performance in pharmaceutical industry. According to the stakeholders, strategic planning, organizational support, knowledge management and technological advancement have significant impact on the success of information technology for decision support. Research limitations / Implications: More research will be required on the theory presented in this thesis “Decision Support Systems: Creating Value for Marketing Decisions in the Pharmaceutical Industry”
Keywords: Business Intelligence, Decision Support Systems, Knowledge Management, Marketing Performance, Organizational support, Qualitative and quantitative study, Strategic Planning, technological innovation